New 'Reference Regimen' in Metastatic Pancreatic Cancer?
Liposomal irinotecan plus chemo in the new NALIRIFOX regimen significantly improved overall survival compared with standard therapy in metastatic pancreatic ductal adenocarcinoma. Medscape Medical News
Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, 2022 Mary Pazdur Award Recipient
Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, executive director of Canopy Cancer Collective and an associate professor at Thomas Jefferson University College of Nursing, was presented with the fifth annual Mary Pazdur Award for Excellence in Advanced
Practice by APSHO, the Advanced Practitioner Society for Hematology and Oncology (APSHO). The award recognizes an exceptional leader,...
Link Between PCOS and Increased Risk of Pancreatic Cancer?
Women with polycystic ovary syndrome (PCOS) may be at a higher risk of developing pancreatic cancer, say researchers reporting an association between the two. Medscape Medical News
Pancreatic Cancer Screening Effective for High-Risk Patients
The study explored a targeted strategy for screening since pancreatic cancer screening is not recommended for the general population. MDedge News
Targeted Radionuclide Boosts Survival in Pancreatic Tumors
A phase 2 trial of lutetium-octreotate in patients with unresectable progressive pancreatic neuroendocrine tumors shows nearly double the 1-year survival rate compared with sunitinib at standard dose. Medscape Medical News
One Third of Pancreatic Cancer Diagnoses Missed on Scans
An analysis of post-imaging pancreatic cancer diagnoses suggests that in 36% of cases, there were signs on CT and MRI scans that had been missed. Medscape Medical News
FDA OKs Selpercatinib for Adults With RET Fusion+ Solid Tumors
The approval expands the drug label to include a variety of RET-positive tumor types, including pancreatic and colorectal cancers. FDA Approvals
Pancreatic Cancer Elevated After Solid Organ Transplant
The incidence of pancreatic cancer was increased among solid organ transplant recipients in comparison with the general population. The study was published as a preprint and has not yet been peer reviewed. First Look
Cancer May Increase Risk of Type 2 Diabetes
Certain cancers, particularly pancreatic malignancies, may increase the risk of developing new-onset type 2 diabetes, meaning that oncologists should consider screening. Medscape Medical News
Exercise Slows Tumor Growth in Pancreatic Cancer
Aerobic exercise slows pancreatic cancer growth in animal models and prolongs survival in both animals and patients, especially when combined with anti-PD1 drugs. Medscape Medical News
